![]() |
![]() |
(11) | Number of the document | C 1632232-2 |
(68) | Number of the document | 1632232 |
(21) | Application number for Supplementary Protection Certificate | PA 2016 043 |
(22) | Date of filing the application | 2016-12-20 |
(41) | Date of publication of the application | 2017-01-10 |
Date of publication of SPC | 2024-09-10 | |
(24) | Date of coming into effect of SPC | 2025-09-03 |
(71) |
Janssen Pharmaceutica NV,
Turnhoutseweg 30, 2340 Beerse,
BE
|
(73) |
Janssen Pharmaceutica NV,
Turnhoutseweg 30, 2340 Beerse,
BE
|
(74) |
Jurga PETNIŪNAITĖ,
AAA Law, A. Goštauto g. 40B, Verslo centras "Dvyniai", LT-03163 Vilnius,
LT
|
(93) | EU/1/16/1112, 2016-06-21 |
(94) | 2030-09-02 |
(95) | Rilpivirino hidrochloridas ir tenofoviro alafenamidas |
SPC granted |